RWE's Lingen Hydrogen Turbine Enters Service as Analysts Back the Stock and Staff Share Buying Continues

RWE has moved its hydrogen-capable gas turbine in Lingen into operation, with partner Kawasaki Heavy Industries, launching a multi-month trial that will test power generation on up to 100% hydrogen. The milestone sits alongside a steady flow of project news and a pair of reaffirmed buy ratings — and all of it now points toward 11 November 2026, when the Essen-based utility publishes its interim report for the first three quarters of 2026 and hosts an investor and analyst conference the same day.

That report is shaping up as the real test of RWE's spending plans. The company intends to invest roughly EUR 9 billion through 2031 in flexible generation, battery storage and hydrogen production, and investors will want to see whether earnings, cash flow and capital needs hang together. A growing project pipeline would be most convincing if the financial performance keeps pace with the build-out; if it does not, the same expansion could invite a more cautious reading.

Staff share purchases and a UK buyback

In its fifth interim disclosure on the German employee share programme, RWE reported the acquisition of 55,000 shares in the past week, taking the total since the programme began on 5 October to 275,000 shares. The company also disclosed purchases under buyback programmes for British group companies: 1,475 RWE shares were acquired in November at an average price of GBP 48.753421 each, for a total of GBP 71,911.296.

Should investors sell immediately? Or is it worth buying Rwe?

Serra Palino comes online

On the operational side, RWE Renewables Europe & Australia commissioned the Serra Palino onshore wind farm in Apulia on 2 November. The facility has a capacity of 47.2 MW and comprises eight turbines. In Germany, RWE Renewables Europe & Australia and the town of Bedburg have also brought their joint wind farm into service, with RWE holding the majority stake.

Two brokers stay bullish

Analysts remain supportive. UBS confirmed its buy recommendation on RWE on Wednesday with a price target of EUR 68, according to media reports, without changing its rating. Jefferies had reaffirmed its buy call on 3 November with a target of EUR 75; analyst Ahmed Farman pointed in his first reaction to the awards for three gas-fired power plants that RWE received about a week earlier. RWE has said it intends to start construction of the first of those plants within a few weeks — a step investors will be watching to see whether announced plans turn into shovels in the ground.

The shares have climbed 29% since the start of the year, which raises the bar for the upcoming figures. After that run, the case for a more durable valuation rests on matching project progress against the financials. The question for shareholders is how much confidence the operational steps already taken can justify before the next report supplies fresh evidence.

For the Lingen trial, the commercial weight could grow if testing confirms the technology's operational readiness — but it remains a test, and results that reveal tougher implementation requirements would argue for a more guarded view. The risk, in short, lies in the gap between project progress and economic payoff. Should the interim statement show that the business can carry the investment programme, the completed commissioning work could reinforce confidence in execution; should the balance between financial capacity and expansion costs tip the other way, the burden of the programme would loom larger.

Ad

Rwe Stock: New Analysis - 9 November

Fresh Rwe information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Rwe analysis...